209 related articles for article (PubMed ID: 35779947)
1. Antinociceptive and Analgesic Effects of (2
Yost JG; Wulf HA; Browne CA; Lucki I
J Pharmacol Exp Ther; 2022 Sep; 382(3):256-265. PubMed ID: 35779947
[TBL] [Abstract][Full Text] [Related]
2. A Pharmacological Evaluation of the Analgesic Effect and Hippocampal Protein Modulation of the Ketamine Metabolite (2R,6R)-Hydroxynorketamine in Murine Pain Models.
Das V; Basovich MB; Thomas CJ; Kroin JS; Buvanendran A; McCarthy RJ
Anesth Analg; 2024 May; 138(5):1094-1106. PubMed ID: 37319016
[TBL] [Abstract][Full Text] [Related]
3. (2R,6R)-hydroxynorketamine (HNK) reverses mechanical hypersensitivity in a model of localized inflammatory pain.
Yost JG; Browne CA; Lucki I
Neuropharmacology; 2022 Dec; 221():109276. PubMed ID: 36198332
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of the ketamine metabolite (2R,6R)-hydroxynorketamine in mice models of pain.
Kroin JS; Das V; Moric M; Buvanendran A
Reg Anesth Pain Med; 2019 Jan; 44(1):111-117. PubMed ID: 30640662
[TBL] [Abstract][Full Text] [Related]
5. Effects of (2R,6R)-hydroxynorketamine in assays of acute pain-stimulated and pain-depressed behaviors in mice.
Hillhouse TM; Partridge KJ; Garrett PI; Honeycutt SC; Porter JH
PLoS One; 2024; 19(4):e0301848. PubMed ID: 38640139
[TBL] [Abstract][Full Text] [Related]
6. BDNF-TrkB signaling-mediated upregulation of Narp is involved in the antidepressant-like effects of (2R,6R)-hydroxynorketamine in a chronic restraint stress mouse model.
Ju L; Yang J; Zhu T; Liu P; Yang J
BMC Psychiatry; 2022 Mar; 22(1):182. PubMed ID: 35291971
[TBL] [Abstract][Full Text] [Related]
7. (2R,6R)-hydroxynorketamine rescues chronic stress-induced depression-like behavior through its actions in the midbrain periaqueductal gray.
Chou D; Peng HY; Lin TB; Lai CY; Hsieh MC; Wen YC; Lee AS; Wang HH; Yang PS; Chen GD; Ho YC
Neuropharmacology; 2018 Sep; 139():1-12. PubMed ID: 29953886
[TBL] [Abstract][Full Text] [Related]
8. Ketamine metabolite (2R,6R)-hydroxynorketamine reverses behavioral despair produced by adolescent trauma.
Elmer GI; Tapocik JD; Mayo CL; Zanos P; Gould TD
Pharmacol Biochem Behav; 2020 Sep; 196():172973. PubMed ID: 32569786
[TBL] [Abstract][Full Text] [Related]
9. Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2
Fukumoto K; Fogaça MV; Liu RJ; Duman C; Kato T; Li XY; Duman RS
Proc Natl Acad Sci U S A; 2019 Jan; 116(1):297-302. PubMed ID: 30559184
[TBL] [Abstract][Full Text] [Related]
10. (
Zanos P; Highland JN; Stewart BW; Georgiou P; Jenne CE; Lovett J; Morris PJ; Thomas CJ; Moaddel R; Zarate CA; Gould TD
Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6441-6450. PubMed ID: 30867285
[TBL] [Abstract][Full Text] [Related]
11. Intranasal (2R, 6R)-hydroxynorketamine for acute pain: Behavioural and neurophysiological safety analysis in mice.
Goswami N; Aleem M; Manda K
Clin Exp Pharmacol Physiol; 2023 Feb; 50(2):169-177. PubMed ID: 36371631
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological evaluation of clinically relevant concentrations of (2R,6R)-hydroxynorketamine.
Shaffer CL; Dutra JK; Tseng WC; Weber ML; Bogart LJ; Hales K; Pang J; Volfson D; Am Ende CW; Green ME; Buhl DL
Neuropharmacology; 2019 Jul; 153():73-81. PubMed ID: 31015046
[TBL] [Abstract][Full Text] [Related]
13. Sex-specific neurobiological actions of prophylactic (R,S)-ketamine, (2R,6R)-hydroxynorketamine, and (2S,6S)-hydroxynorketamine.
Chen BK; Luna VM; LaGamma CT; Xu X; Deng SX; Suckow RF; Cooper TB; Shah A; Brachman RA; Mendez-David I; David DJ; Gardier AM; Landry DW; Denny CA
Neuropsychopharmacology; 2020 Aug; 45(9):1545-1556. PubMed ID: 32417852
[TBL] [Abstract][Full Text] [Related]
14. Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit.
Yao N; Skiteva O; Zhang X; Svenningsson P; Chergui K
Mol Psychiatry; 2018 Oct; 23(10):2066-2077. PubMed ID: 29158578
[TBL] [Abstract][Full Text] [Related]
15. Prelimbic cortex miR-34a contributes to (2R,6R)-hydroxynorketamine-mediated antidepressant-relevant actions.
Ye L; Xiao X; Xu Y; Zheng C; Chen S; Luo T; Li Z; Du Y; Yuan Y; Li L; Liu B; Qin W; Chou D
Neuropharmacology; 2022 May; 208():108984. PubMed ID: 35131296
[TBL] [Abstract][Full Text] [Related]
16. Target deconvolution studies of (2R,6R)-hydroxynorketamine: an elusive search.
Bonaventura J; Gomez JL; Carlton ML; Lam S; Sanchez-Soto M; Morris PJ; Moaddel R; Kang HJ; Zanos P; Gould TD; Thomas CJ; Sibley DR; Zarate CA; Michaelides M
Mol Psychiatry; 2022 Oct; 27(10):4144-4156. PubMed ID: 35768639
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant-relevant concentrations of the ketamine metabolite (2
Lumsden EW; Troppoli TA; Myers SJ; Zanos P; Aracava Y; Kehr J; Lovett J; Kim S; Wang FH; Schmidt S; Jenne CE; Yuan P; Morris PJ; Thomas CJ; Zarate CA; Moaddel R; Traynelis SF; Pereira EFR; Thompson SM; Albuquerque EX; Gould TD
Proc Natl Acad Sci U S A; 2019 Mar; 116(11):5160-5169. PubMed ID: 30796190
[TBL] [Abstract][Full Text] [Related]
18. The potent analgesia of intrathecal 2R, 6R-HNK via TRPA1 inhibition in LF-PENS-induced chronic primary pain model.
Liu AR; Lin ZJ; Wei M; Tang Y; Zhang H; Peng XG; Li Y; Zheng YF; Tan Z; Zhou LJ; Feng X
J Headache Pain; 2023 Oct; 24(1):141. PubMed ID: 37858040
[TBL] [Abstract][Full Text] [Related]
19. (R)-Ketamine exerts antidepressant actions partly via conversion to (2R,6R)-hydroxynorketamine, while causing adverse effects at sub-anaesthetic doses.
Zanos P; Highland JN; Liu X; Troppoli TA; Georgiou P; Lovett J; Morris PJ; Stewart BW; Thomas CJ; Thompson SM; Moaddel R; Gould TD
Br J Pharmacol; 2019 Jul; 176(14):2573-2592. PubMed ID: 30941749
[TBL] [Abstract][Full Text] [Related]
20. (S)-norketamine and (2S,6S)-hydroxynorketamine exert potent antidepressant-like effects in a chronic corticosterone-induced mouse model of depression.
Yokoyama R; Higuchi M; Tanabe W; Tsukada S; Naito M; Yamaguchi T; Chen L; Kasai A; Seiriki K; Nakazawa T; Nakagawa S; Hashimoto K; Hashimoto H; Ago Y
Pharmacol Biochem Behav; 2020 Apr; 191():172876. PubMed ID: 32088360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
